DEA Plants The Seed For Rescheduling Marijuana: What's Next? (Podcast)

In this episode of "The Eyes on Washington Podcast," Public Policy & Regulation attorneys Michael Werner, Sara Klock, Joshua Odintz and Ed Perlmutter discuss the proposed rule by the U.S. Drug Enforcement Administration (DEA) to move marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act. They explore how the reclassification could impact federal and state regulation, U.S. tax policy, banking rules and product approvals. The discussion also highlights the need for stakeholders to carefully engage with these evolving regulatory changes.

Podcast Transcript

Michael Werner: Hello and welcome to the latest in a series of podcasts from the Holland & Knight Public Policy & Regulation team. I'm Michael Werner. I am the head of the firm's life sciences and FDA group. I'm joined by three of my colleagues today, Sara Klock, Josh Odintz and Ed Perlmutter. And we're going to be talking about the new proposed rule issued by the U.S.